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Abstract
Invariant natural killer T cells (iNKT) are a prevalent population of innate-like T cells in mice, but quite rare in humans that
are critical for regulation of the innate and adaptive immune responses during antimicrobial immunity, tumor rejection, and
inflammatory diseases. Multiple transcription factors and signaling molecules that contribute to iNKT cell selection and
functional differentiation have been identified. However, the full molecular network responsible for regulating and maintaining iNKT populations remains unclear. MicroRNAs (miRNAs) are an abundant class of evolutionarily conserved, small,
non-coding RNAs that regulate gene expression post-transcriptionally. Previous reports uncovered the important roles of
miRNAs in iNKT cell development and function using Dicer mutant mice. In this review, we discuss the emerging roles
of individual miRNAs in iNKT cells reported by our group and other groups, including miR-150, miR-155, miR-181, let7, miR-17 ~ 92 cluster, and miR-183-96-182 cluster. It is likely that iNKT cell development, differentiation, homeostasis,
and functions are orchestrated through a multilayered network comprising interactions among master transcription factors,
signaling molecules, and dynamically expressed miRNAs. We provide a comprehensive view of the molecular mechanisms
underlying iNKT cell differentiation and function controlled by dynamically expressed miRNAs.
Keywords iNKT cells · microRNAs · miR-155 · miR-150 · miR-183-96-182 · miR-181 · miR-17~92 · let-7

Introduction
MicroRNAs (miRNAs) are 18- to 23-nucleotide, singlestranded RNAs that modulate the stability and translation
of mRNAs at the post-transcriptional level [1]. To date, more
than 2500 mature human miRNAs have been identified [2].
Over the past decade, miRNAs have been increasingly recognized as a discrete layer of gene regulation controlling
the cellular development and physiological workings of the
immune system, and miRNAs are the best-characterized
class of noncoding RNAs in regard to genetic expression and
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cellular function [3]. miRNAs are encoded in the genome as
miRNA genes and are transcribed by RNA polymerase II,
which generates a primary miRNA (pri-miRNA) molecule
[4]. This primary transcript is then cleaved in the nucleus
by the conserved endogenous double-strand RNaseIII-type
endonuclease Drosha, resulting in a precursor miRNA (premiRNA) molecule. The pre-miRNA translocates to the
cytoplasm with assistance from Exportin 5, where it is processed by the enzyme Dicer, which cleaves it into a doublestranded miRNA duplex. The resulting 18- to 23-nucleotide
long single-stranded mature miRNA is then loaded onto the
RNA-induced silencing complex (RISC) [5], which interacts
with its target mRNAs via complementary binding, causing either post-transcriptional degradation or translational
repression [6].
Invariant natural killer T (iNKT) cells are a subset of regulatory T cells that co-express a rearranged T
cell receptor α chain (Vα14-Jα18 in mice; Vα24-Jα18
in humans) in combination with a limited set of Vβ
chains (Vβ8.2, 7 or Vβ2 in mice; Vβ11 in humans) [7].
iNKT cells branch out of the conventional T cell lineage at the double-positive (DP) thymocyte stage and are
selected by homotypic DP thymocytes expressing CD1d,
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a nonclassical MHC-I–like molecule [8, 9]. After positive
selection, signals initiated through TCR (T cell receptor)
and SLAM (signaling lymphocytic activation molecule)
family receptors allow iNKT cells to progress to the earliest detectable subset, stage 0, where cell surface molecules CD24 and CD69 are expressed [10]. Subsequently,
thymus iNKT cells proliferate and proceed through three
sequential maturation stages that are phenotypically distinguished by the variable expression of CD24, CD44,
and NK1.1 as follows: stage 1 (CD24lowCD44lowNK1.1−),
st age 2 
( CD24 low CD44 hi NK1.1 − ), and st age 3
low
(CD24 CD44hiNK1.1+) [11, 12]. Upon antigenic stimulation, iNKT cells rapidly and robustly produce a broad
range of cytokines, which allows them to modulate the
functions of a variety of immune cells and regulate both
innate and adaptive immune responses [13, 14].
Recently, studies on iNKT cell development focus on the
lineage differentiation model in addition to the linear maturation model [15]. Three major functionally distinct iNKT
cell subsets originate in the thymus—iNKT1, iNKT2, and
iNKT17—with subset delineation based on transcription
factor expression and cytokine profiles. Each subset can be
further characterized by the expression of distinct transcription factors that correlate with a cytokine secretion profile
upon activation. iNKT1 cells express T-bet, predominantly
secrete IFN-γ, and are mainly equivalent to stage 3 iNKT
cells; iNKT17 cells have intermediate levels of PLZF, are
RORγt+ and secrete IL-17 and IL-23 [16, 17]. iNKT2 cells
are not readily defined, and typically, iNKT2 express high
levels of GATA3, PLZF, and IL17RB, and secrete IL-4 and
IL-13 [15, 18, 19]; and more precisely, recent high dimensional single-cell RNA sequencing studies indicated the
transcriptional heterogeneity and developmental path of
iNKT cells development [20–22]. These new discoveries
in iNKT subset differentiation, along with the recent global
transcriptional analysis of iNKT cell development and functional subsets, have revealed that iNKT cell development and
differentiation in the thymus are controlled by a complex
signaling network, which ensures proper induction of genes
essential for iNKT cell differentiation and maturation. All
of these iNKT cell subsets differentiation and population
expansion mechanisms depend on tunable responses that are
sensitive to minor perturbations in protein expression cascades. In particular, antigen receptor signaling can be quantitatively manipulated through minor changes in expression
that limit regulators in the downstream signaling pathways,
such as the PI3K and NF-κB. This type of manipulation can
be carried out by multiple epigenetic mechanisms, including
miRNA regulation. In this review, we provide an overview
of the current literatures to outline the roles of miRNAs at
various stages of iNKT cell development, differentiation,
and activation.
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Specific and dynamic miRNA expression in T
and iNKT cells
Unique spatial and temporal expression patterns in distinct hematopoietic cell lineages suggest that miRNAs
may play multiple roles in immune cell development,
differentiation, and function, which have been explored
over the past decade [23–25]. The dynamic, cell-specific
regulation of miRNA expression during sequential stages
of T cell development has been well documented [26, 27].
Even though T cells at early DP developmental stages
have relatively high miRNA expression levels, individual miRNAs show dynamic changes in distinct thymic
T cell subpopulations, including at the DP, double-negative (DN), and single-positive (SP) stages [26, 28]. In
addition to defining the miRNA genome (miRNome) of
mouse lymphocyte subsets, a recent study combined highthroughput microRNA-seq, mRNA-seq, and CHIP-seq to
gain insights into the epigenetic regulation of lymphocyte
miRNA genes [29]. This study offers a complete view of
the mouse immune system miRNome while pointing out
that miRNA abundance results from the interplay of epigenetic, transcriptional, and post-transcriptional mechanisms. To generate a comprehensive view of the human
lymphocytic miRNome, Rossi et al. isolated 17 human T
and B lymphocyte subsets from peripheral blood mononuclear cells and sorted them by flow cytometry, analyzing
the miRNA expression profiles by TaqMan low-density
arrays (TLDAs) [30]. This study defined human lymphocyte miRNA expression signatures and identified 29 miRNAs that showed subset-specific expression patterns. To
determine the miRNA profiles expressed by thymic iNKT
cells relative to mature thymic conventional T cells, miRNAs from mouse H
 SAlow thymic iNKT and T cells were
profiled with locked nucleic acid (LNA)-based miRNA
microarrays [31]. Among 70 miRNAs detected, the study
revealed 17 miRNAs that were differentially expressed in
thymic iNKT cells compared to thymic conventional T
cells. Real-time PCR confirmed that the thymic iNKT cells
had higher expression of miR-21 and lower expression of
let-7g, miR-106a, miR-34b-3p, miR-17, miR-30c, miR106b, miR-16, miR-467a, miR-467b, miR-690, miR-15b,
miR-669f, and miR-150 than T cells. These miRNA signatures exhibited features of activated/effector iNKT cells.
Dynamic changes of miRNA expression during the
sequential stages of T cell development have been well
documented [26]. Coinciding with this phenomenon, studies from other groups, including ours, have shown dynamic
changes in levels of individual miRNAs during distinct
iNKT cell developmental stages. While miR-142 [32]
and miR-96 [33] are equally expressed at developmental
stages 1 to 3, the following molecules are expressed at

microRNA dynamic expression regulates invariant NKT cells	

higher levels in stage 1 and lower levels in stages 2 and 3:
miR223 [34], miR-155 [35, 36], miR-150 [37, 38], miR182, miR-183 [33], miR-181a and b [39], miR-30c and
e [32]. Also, miR-25 and miR-92 are selectively downregulated at stage 3 [32], whereas miR-21a, miR-23b, and
miR-30a and b are upregulated at stage 3 [32]. Finally,
miR-17, miR-18a and b, miR-19a and b, miR-20a and b,
miR-93, miR-106a and b, and miR-363 are selectively
up-regulated at stage 2 [32]. The specific and dynamic
miRNA expression changes in iNKT cells strongly suggest
a potential role for miRNAs in maintaining and balancing
signaling networks during iNKT cell development, maturation, and activation.

Global miRNA regulation in iNKT cells
As knowledge of multiple defined pathways has contributed
to the identification of the miRNA pool, initial studies determining the importance of miRNAs in the murine immune
system utilized a broad disruption of all miRNAs in specific
cell types by deleting key proteins, such as Dicer, required
for miRNA biogenesis. With the deletion of Dicer, miRNA
gene expression profiles display remarkable changes within
immune cells, including iNKT and conventional T cells [31,
40]. Consistent with the distinct miRNA expression patterns,
the overall critical regulatory roles of miRNAs in hematopoiesis, including during the development and maturation
of iNKT cells, have been revealed through the use of Dicer
mutation animal models [31, 40–42]. To investigate the role
of miRNAs in iNKT cell regulation, our group generated
a hematopoietic progenitor-specific Dicer deletion mouse
model (Tie2-cre;Dicerflox/flox), which uncovered the critical relevance of miRNAs in iNKT cell development and
function [40]. Our results indicate that Dicer deletion leads
to a severe abrogation of iNKT cells in both the thymus
and in peripheral organs. Strikingly, Dicer-deficient iNKT
cells were not able to properly mature and showed dramatic
blockade in the transitions from DP to DN or CD4 + SP
and from NK1.1- immature stage to NK1.1 + mature stage
[40]. Moreover, Dicer-deficient iNKT cells show remarkably reduced activation and cytokine secretion upon both
TCR-dependent and TCR-independent stimulation. Soon
after our report, Fedeli et al. independently identified the
critical role of miRNAs in iNKT cell development using
CD4-Cre- and Lck-Cre-mediated thymus-specific Dicer
knockout (KO) mouse models [31]. Their results indicate
that defective iNKT cell homeostasis in thymus-specific
Dicer deletion mice is presumably caused by a mitotic defect
and increased iNKT cell death [31]. In agreement with these
results, our studies using the similar thymus-specific Dicer
deletion mouse model further confirm the profound developmental and functional defects in Dicer deletion iNKT cells
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[43]. In addition to iNKT cells, Lck mediated Dicer deletion
showed that in a profound loss of conventional immature and
mature T cells [44]. Furthermore, T cell-specific Dicer deletion leads to impaired conventional T cell development and
aberrant T helper cell differentiation and reduced T regulatory cell ( Treg) development [45, 46]. These studies demonstrated the critical roles of Dicer-dependent miRNAs in
the signaling pathways and networks controlling iNKT cell
development and function. Meanwhile, they also emphasize
the necessity of identifying the specific miRNAs and related
molecular mechanisms contributing to iNKT cell maturation, homeostasis, and function.

Individual miRNAs regulate iNKT cell
development, differentiation, and activation
Even though genetic studies have clearly demonstrated the
central role of miRNAs and miRNA-dependent pathways
in various aspects of iNKT cell biology, identification of
the roles of individual miRNAs and their related molecular
mechanisms is essential for comprehensively understanding
the signaling pathways and molecular networks in iNKT cell
developmental regulation. The principle that miRNAs target
multiple mRNAs to form regulatory networks is evident in
multiple cell types, diseases, and animal models [47, 48].
The positive or negative regulation by individual miRNAs
is often achieved through the modulation of key signaling
pathways, and multiple miRNAs can coordinately regulate
shared signaling pathways to induce integrated broader
changes in related signaling networks [47, 49, 50]. Through
years of effort, multiple laboratories have independently
identified several individual miRNAs critically involved in
iNKT cell development, differentiation, activation, and function, which will be briefly reviewed here (Fig. 1; Table 1).

miR‑150
miR-150 has been reported to be particularly expressed in
mature B and T cells, but not in their progenitors [51]. The
ectopic expression of miR-150 in hematopoietic progenitor
cells leads to a substantially reduced number of mature B
cells, especially B1 cells, by blocking B cell development
during the transition from the pro-B to pre-B cell stage
[52]. The importance of miR-150 in B cell development
was further demonstrated through gain- and loss-of-function mouse models, but no apparent T cell developmental defects were identified except a slightly delayed T cell
development observed in miR-150 transgenic mice early in
life [53]. Furthermore, c-Myb, a predicted target of miR150, was found to play a crucial role in modulating B cell
development [53]. Bezman NA et al. and our group have
found that, in addition to expression in conventional B and
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Fig. 1  microRNA dynamic expression mediates iNKT cell development. iNKT cells are selected from DP thymocytes and proceed
through 4 sequential stages (stage 0–3) that are phenotypically distinguished by the expression of CD24, CD44, and NK1.1. During development, iNKT cells differentiate into iNKT1, iNKT2, and iNKT17
cells based on the activity of the transcription factors T-bet, PLZF,
and RORγt. Dynamically expressed miRNAs have been identified
that regulate iNKT cell development. The effects of these miRNAs
depend on their timing of expression throughout iNKT cell development. miR-181ab, miR-183-96-182 cluster (miR-183C), and miR-155

control the early development stages of iNKT cell, whereas miR17 ~ 92, miR-150, and let-7 direct the final steps of iNKT cell maturation via targeting multiple genes that critical for iNKT cell development. During iNKT cells development, miRNAs showing in red
(miR-150 and let-7) are gradually increased; miRNAs showing in
blue (miR-181 and miR-155) are gradually down regulated; miRNA
in yellow (miR-183C) is repressed in DP, increased in ST0, and then
gradually down regulated during iNKT cells development; miRNA in
grey (miR-17 ~ 92) is highly expressed in ST2. DP double positive,
ST stage, pNKT iNKT precursor

T cells, miR-150 is expressed in iNKT cells and is gradually
upregulated during iNKT cell maturation in the thymus [37,
38]. Using conventional miR-150 KO mice, we found that
miR-150 deletion significantly reduces iNKT cell frequency
and cell number, and partially blocks iNKT cell maturation
from stage 2 to stage 3 in both thymus and peripheral organs.
Moreover, unlike Dicer-deficient iNKT cells, miR-150–deficient iNKT cells display increased IFN-γ production after
stimulation with α-GalCer in vivo, but not after phorbol
myristate acetate/ionomycin treatment, indicating that miR150 may negatively regulate iNKT activation mainly through
targeting proximal components of TCR signaling pathway
[37]. In contrast to the maturation and functional defects in
miR-150-deficient iNKT cells, the miR-150-deficient conventional T cells, Tregs, and γδ T cells from thymus and
peripheral organs show no apparent phenotypic changes,
suggesting that iNKT cell lineage-specific regulation is
mediated by miR-150. Notably, Lanier’s group reported
that overexpression of miR-150 also dramatically reduces
the iNKT cell number and partially blocks iNKT cell development at the transition from stage 0 to stage 1, resulting in
an increased proportion of CD24hi NK1.1− iNKT cells compared to wild type [38]. These results indicate the essential
role of dynamic miR-150 regulation in the development of
iNKT cells [38, 54, 55]. Deficiency in the potential miR-150
target c-Myb in the thymus results in a complete absence

of iNKT cells. c-Myb plays a central role in priming DP
thymocytes to enter the iNKT cell lineage by simultaneously regulating CD1d expression, the half-life of DP cells,
and the expression of SLAMF1, SLAMF6, and SAP [56].
c-Myb is also highly expressed in immature iNKT cells and
downregulated during iNKT cell maturation, which is the
opposite of miR-150 dynamic expression changes during
iNKT cell maturation. Furthermore, in miR-150 KO mice,
c-Myb expression is significantly upregulated in both immature (stages 1 and 2) and mature (stage 3) iNKT cells [37],
and partial ablation of c-Myb phenocopies impaired iNKT
cell development in miR-150Tg mice[38]. These data suggest that a dynamically and tightly regulated expression of
miR-150 is required for optimal iNKT cell development by
controlling the levels of c-Myb expression.
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miR‑181
The miR-181 family is composed of six mature miRNAs
encoded in three independent miRNA clusters: miR-181a1,
miR-181a2, miR-181b1, miR-181b2, miR-181c, and miR181d [57]. One of these clusters, miR-181a1b1, has been
shown to be particularly important in conventional T cell
selection and activation. Inhibition of miR-181 in thymocytes impairs positive and negative T cell selection
and decreases TCR sensitivity, while overexpression of
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Table 1  miRNAs and their potential targets involved in iNKT cell development
miRNA

miR-155

Expression

Potential targets Function

Up-reg

Down-reg

Stages 1/2

Stage 3

Jarid2
Rictor
Tab2
Est1
Itk

miR-183C

Stages 1/2

DP stage, stage 3 Egr1/2
Foxo1
Foxo3

miR-181

DP, Stage 1

Stage 3

Pten
Ptptn11
Ptptn22
Dusp6
Aplp2
Atp1b1

Klf6
Man2a1
Samhd1

miR-150

Stage 3

Stages 1/2

Txndc5
c-Myb

let-7

Stages 1/2

Stage 3

Zbtb16

miR-133b

–

–

Th-pok

A negative regulator of
Zbtb16 at later stage
Control iNKT17 differentiation and iNKT survival
TGF-b activated kinase
1-binding protein 2
Critical for cell maturation
Inducible T cell kinase,
downstream of TCR
A positive regulator of
Zbtb16 at early stage
Control iNKT17 effector
function
Control NF-kB signaling in
T cells
Governs iNKT cell homeostasis
Phosphatases

Modulates phosphoinositidemediated calcium flux
Catalyzes the hydrolysis
of ATP coupled with the
exchange of Na + and
K + ions
A transcriptional activator
Catalyzes the first step in the
biosynthesis of complex
N-glycans
A modulator of the innate
immune response
Functions as antioxidant
Control T cell proliferation
and differentiation
A master of iNKT cell lineages
Control iNKT17 differentiation

Signaling pathway

References

[35]
mTORC2 signaling
TGF-β & NF-κB signaling
[36]

[33]
NF-κB signaling
NF-κB signaling
PI3K-PTEN signaling

[60]

Negatively regulate TCR
signaling

[39]

[32]

[37, 38]
[94]
[108]
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Table 1  (continued)
miRNA

Expression

Potential targets Function

Signaling pathway

Up-reg

Down-reg

miR-30e,-c

Stage 1

Stages 2/3

Timp2

Inhibitor of the matrix metalloproteinases

miR-30a,-b

Stage 3

Stages 1/2

Timp2

Inhibitor of the matrix metalloproteinases

miR-23

Stage 3

Stages 1/2

Sgk1

Regulate cellular progress
such as cell survival

miR-223

Stages 1/2

Stage 3

–

–

miR-21

Stage 3

Stages 1/2

–

–

miR-17 ~ 92

Stage 2

Stages 1/3

Sgk1

Regulate cellular progress
such as cell survival

Timp2

Inhibitor of the matrix metalloproteinases

Tgfbr2

TGF-β signaling
Binds TGF-beta, regulate
the transcription of genes
related to cell proliferation,
cell cycle arrest

miR-106a ~ 363 Stage 2

Stages 1/3

Tgfbr2

miR-106b ~ 25

Stage 2

Stages 1/3

Tgfbr2

miR-495

–

Sgk1

Regulate cellular progress
such as cell survival

miR-495

–

Timp2

Inhibitor of the matrix metalloproteinases

miR-142

Equally expressed at stage 1–3

Sgk1

Regulate cellular progress
such as cell survival

References

[32]

Down-reg downregulated, Up-reg upregulated, DP double positive, iNKT invariant natural killer T cell

miR-181a in mature T cells increases their TCR sensitivity
to peptide antigens [58]. In addition, miR-181 reduces the
TCR engagement threshold for cellular responses through
targeting multiple phosphatases, including PTPN22, SHP2, DUSP5, and DUSP6 [58]. In innate immunity, miR-181
promotes human NK cell development from CD34+ hematopoietic progenitor cells and IFN-γ production in primary
CD56+ NK cells, partially through the suppression of the
Notch signaling inhibitor NLK [59].
In addition to having an effect on conventional T cells,
miR-181 has been shown to play an essential role in iNKT
cell development, as was shown in two parallel studies
[39, 60]. Deletion of the miR-181a1b1 cluster was shown
to block iNKT cell development during the metabolically
demanding transition from stage 0 to 1 and to almost completely abrogate early iNKT cell development, resulting in
dramatically reduced iNKT cell numbers in the thymus and
in peripheral organs [39, 60]. These findings suggest that
iNKT cell development is essentially dependent on miR181. Furthermore, miR-181a1b1 deletion results in reduced
iNKT cell activation upon TCR stimulation, an altered TCR
repertoire, and reduced peripheral iNKT cell function [39].

13

Completely eliminating the miR-181 target PTEN (phosphatase tensin homolog) restores iNKT cell numbers in
miR-181a1b1 deficient mice [60]. This indicates a critical
role for miR-181 in regulating phosphoinositide 3-kinase
(PI3K) signaling downstream of TCR activation and suggests that miR-181 may possibly control mTOR (mammalian
target rapamycin) signaling and regulation of global metabolic fitness. Interestingly, iNKT cell development appears
to be particularly sensitive to alterations in metabolic fitness, especially during development from stage 0 to stage 1,
which likely reflects multiple unique features in iNKT cell
ontogenesis [61, 62]. Moreover, increasing the concentration
of TCR ligands or elevating levels of a Vα14Jα18 TCRα
chain [63] could rescue defective iNKT cell development in
miR-181a1b1 KO mice, which indicates the important role
of miR-181 in setting a TCR signaling threshold for agonist
selection through high-affinity TCR ligands [39]. The TCR
signaling threshold alteration seen during iNKT cell development in miR-181a1b1 KO mice maybe, at least partially,
related to the modest upregulation of miR-181 target genes
such as Ptpn22, Shp-2, and Dusp6, which negatively regulate
TCR signaling [39]. Therefore, the paucity of iNKT cells
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in miR-181a1b1 deficient mice most likely results from a
coordinated interplay of players that regulate TCR and PI3K
signaling, which has been well-documented in the control of
iNKT cell selection, population expansion, and homeostasis.

miR‑155
miR-155 is processed by Dicer from BIC (B cell integration cluster), a non-coding transcript highly expressed in
B cells, T cells, and in monocytes/macrophages. In Treg
cells, miR-155 is directly regulated by FoxP3 and facilitates Treg homeostasis by targeting SOCS1 (suppressors of
cytokine signaling1), leading to increased sensitivity of the
IL-2 receptor to IL-2 [64, 65]. Beyond the role of miR-155
in Treg homeostasis, Baltimore and colleagues have noted
the upregulation of miR-155 as a consistent feature of the
mammalian inflammatory response [66]. Both B and T lymphocytes display a similar induction of miR-155 in response
to activating stimuli [67, 68], and other studies using miR155 gene targeting mouse models have further demonstrated
a broad role of miR-155 in the immune system, including
for B cell memory formation, Th1 and Th17 cell-dependent
tissue inflammation, Th2 cell differentiation, and C
 D8+ T
cell effector function, which have been comprehensively
reviewed previously [3, 49, 69–75]. High expression of
miR-155 is implicated in human B cell malignancies, which
aligns with the B cell proliferative disorders observed in
miR-155 transgenic mice [76, 77]. Using a thymus-specific
(Lck-cre) miR-155 over-expression mouse model, Burocchi
and colleagues found the crucial role of tightly controlled
miR-155 expression in the development of iNKT cells [36].
Overexpression of miR-155 results in a substantial block of
iNKT cell maturation at the stage 2 to stage 3 transition in
both thymus and in peripheral organs, which leads toward
an overall reduction of peripheral iNKT cells, including in
the liver, spleen, and bone marrow. These differentiation and
maturation iNKT cell defects induced by miR-155 overexpression were shown to be cell autonomous. Furthermore,
the transcription factors Ets1 and Itk have been identified as
targets of miR-155 during iNKT cell differentiation [36].
Both Itk and Ets1 are also linked to TCR signaling [78] and
may be targeted by miR-155 in different cell types [79, 80].
Both Ets1 KO [81, 82] and Itk KO [83] mice display a defect
in iNKT maturation at stage 2 to stage 3 transition, which
phenocopies Lck-miR-155 transgenic mice. The expression
of Ets1 and Itk is consistently downmodulated in miR-155
transgenic iNKT cells, except in stage 1, which could be due
to a shorter isoform of the 3′-UTR during stage 1 development. Moreover, at both transcriptional and protein levels,
Ets1 and Itk are dynamically upregulated in wild type mice
during thymic iNKT cell maturation, which is reciprocally
correlated to the dynamic downregulation of miR-155.
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Of note, our recent study using a knock-in (KI), thymic
cell-specific miR-155 overexpression mouse model showed
an additional mechanism underlying miR-155 regulation
of iNKT cells [35]. RNA-seq analysis of sorted stage1/2
NK1.1− and stage 3 NK1.1+ cells showed that potential
miR-155 targets, including Jarid2, Rictor, and Tab2, were
significantly repressed in miR-155 overexpressing iNKT
cells. Jarid2 is a member of the JmjC domain-containing
protein family, a novel component of polycomb repressive
complex 2. A previous study has confirmed that Jarid2 is
a negative regulator of Zbtb16 (encoded by PLZF), which
is mediated by H3K9me3 demethylation at a later stage of
iNKT cell development [84]. Of note, the iNKT phenotype
in a T cell-specific Jarid2 deletion closely resembles what
was observed in miR-155 KI mice, as judged by the disturbed differentiation of iNKT1/2 cells. Rictor is an obligatory component of mTORC2 [85], and the defective iNKT
phenotype in Rictor KO mice is reminiscent of miR-155 KI
iNKT cells, particularly in regard to diminished iNKT17 lineage differentiation [86, 87]. Furthermore, miR-155 overexpressing iNKT cells also show downregulation of the NF-κB
signaling pathway, which may possibly occur through direct
targeting of Tab2, an upstream activation kinase complex
component of NF-κB [88]. Overall, the dynamic expression
of miR-155 and its regulation in thymic iNKT cells is essential for the development, functional lineage differentiation,
and homeostasis of iNKT cells [35, 36]. It should be mentioned that unlike dramatic phenotype change of iNKT cell
with miR-155 overexpression, loss of miR-155 showed a
minor role in the development of iNKT cells, and no effect
on peripheral iNKT cells [89]. It is possible that loss of miR155 is compensated for by other miRNAs or other proteins,
in which would account for normal iNKT cell development
in miR-155 deficient mice.

let‑7
The let-7 (lethal-7) family encompasses the most highly
abundant miRNAs in the human genome and consists of
12 to 14 individual members encoded on different chromosomes in mammals [90]. Let-7 miRNA family members are
highly conserved across the majority of bilateral species,
including mammals [91]. And the potential target genes of
let-7 are involved in a variety of cellular functions, such
as cell-cycle progression, metabolism, and oncogenesis
[92, 93]. To investigate the regulatory roles of let-7 miRNAs during T cell differentiation, Singer’s group created a
mouse model with reduced thymus-specific let-7 miRNA
expression. Their strategy took advantage of the fetal protein LIN28, which prevents let-7 precursor molecules from
being processed into the functionally mature miRNAs [94].
They found that in LIN28 transgenic mice, where the T cellspecific human CD2 promoter/enhancer was used to drive
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LIN28 expression, the frequency of SP CD8 + memory-like
populations in the thymus were increased, possibly due to
an increased number of IL-4 producing cells. In addition
to this phenotype, LIN28 transgenic mice showed dramatically increased iNKT2 and iNKT17 but decreased iNKT1
frequencies, indicating a requirement for let-7 miRNAs in
iNKT thymocyte terminal differentiation. Although the
overall number of thymic iNKT cells in LIN28 transgenic
mice remains comparable to wild type, higher expression
of let-7 miRNAs quantitatively inhibits the generation of
iNKT thymocytes in a cell-intrinsic manner [94, 95]. The
transcription factor PLZF (promyelocytic leukemia zinc
finger) belongs to the BTB-zinc finger family and is the signature transcription factor expressed in innate-like T cells,
including iNKT and γδT cells [96]. In iNKT cells, PLZF
expression is induced by Egr2 after iNKT cell positive
selection, and Egr2 is one of the earliest transcription factors induced by TCR signaling [97]. A deficiency in PLZF
leads to a dramatic interruption of iNKT cell development.
The few iNKT cells in PLZF deficient mice are phenotypically immature with defective cytokine secretion [95, 98]
In line with the iNKT and T cell phenotypes in let-7 and
PLZF mutant mice, let-7 miRNAs have been shown to target Zbtb16 mRNA (which encodes PLZF) to post-transcriptionally inhibit PLZF protein expression. As the expression
of let-7 miRNAs is enhanced as iNKT cells mature, PLZF
expression is decreased. The dynamic expression changes of
PLZF and let-7 miRNAs in opposite directions emphasizes
the key role of let-7 in regulating PLZF expression during
iNKT cell differentiation and maturation [94]. Furthermore,
let-7 miRNAs are dynamically upregulated during iNKT cell
development and maturation in the thymic medulla through
exogenous stimuli, including IL-15, vitamin D, and retinoic
acid. One might speculate that the elevated and prolonged
TCR-induced expression of Egr2 in iNKT cell precursors
activates PLZF transcription, which may promote iNKT cell
development and acquisition of effector phenotypes [97]. As
iNKT cell differentiation progresses, exogenous stimuli may
induce the upregulation of let-7, which concomitantly downregulates PLZF, thus supporting a potential model where
increased let-7 expression in iNKT cells at stage 2 results in
differentiation and maturation toward iNKT1 cells, rather
than iNKT2 and iNKT17 cells [94]. These results suggest
that a temporal, specific, and dynamic expression pattern of
miRNAs regulates iNKT cell effector differentiation.

miR‑183‑96‑182
The miR-183-96-182 cluster (miR-183C) is a family of
miRNAs with evolutionarily conserved sequence homology
and genomic organization and comprises three molecules:
miR-183, miR-96, and miR-182 [99]. Our recent study has
shown that miR-183C regulates iNKT cell development
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and effector function through targeting multiple transcription factors [33]. Of these miRNAs, miR-183 and miR-182
are severely repressed in the DP stage, dramatically upregulated in stage 1, and then gradually downregulated in stages
2 and 3. However, miR-96 is evenly repressed throughout
iNKT cell development. The number of iNKT cells in miR183C KO mice is reduced twofold in the thymus, and tissue-resident iNKT cells show a modified distribution, with
a reduced level of iNKT1 cells, increased level of iNKT2
cells, and unchanged iNKT17 cells. The developmental
defect of iNKT cells in the absence of miR-183C is cellintrinsic. This study also showed that miR-183C regulates
iNKT cell development via targeting Foxo3, Foxo1, Egr1,
and Egr2, which may be required for iNKT development
and function. Egr1 and Egr2 are the earliest transcription
factors induced by TCR signaling and play a critical role
in the positive selection of iNKT cells [97, 100]. In the DP
stage, repressed miR-183C may promote upregulation of
Egr1 and Egr2 expression, consequently supporting iNKT
cell selection [33]. While upregulated, Foxo3 could interrupt
the NF-κB signaling pathway by binding NF-κB RelA in
the cytosol and preventing RelA nuclear translocation [101],
and miR-183C might target Foxo3. NF-κB is thought to be
critical for iNKT cell maturation [102]. In fact, the iNKT
phenotype observed in mice that have deletions in various
NF-κB components closely resembles the iNKT phenotype
of miR-183C–deficient mice. Finally, the study observed that
IL-17 production in iNKT cells from the thymus and from
peripheral organs of miR-183C KO mice is reduced, even
though the differentiation of RORγt-expressing iNKT17
cells is unchanged. A recent study from Chen’s lab demonstrated that miR-183C enhances IL-17 production and pathogenic function in Th17 cells through targeting Foxo1, which
inhibits RORγt-induced IL-1R1 expression and subsequent
IL-17 production, without affecting RORγt expression [103].
Consistently, this study found that Foxo1 expression in iNKT
cells is significantly upregulated in the absence of miR-183C
and showed that iNKT cells with a Foxo1 deletion have dramatically increased IL-17 production. These data indicate
that miR-183C is involved in maintaining iNKT17 effector
function through targeting Foxo1. Taken together, miR-183C
plays a subtle but indispensable role in iNKT cell development, differentiation, and effector function via targeting
multiple genes.

miR‑17 ~ 92 family clusters
The miRNAs discussed up until now (miR-150, miR-155,
miR-181, miR183C, and let-7) have been shown to play independent roles in iNKT cell development. However, deleting
them results in defects that only partially recapitulate those
found in iNKT cells with a Dicer deletion. Recently, a study
by Fedeli et al. demonstrated that miR-17 ~ 92 family clusters

microRNA dynamic expression regulates invariant NKT cells	

play a role in controlling iNKT cell development [32]. The
miR-17 ~ 92 family clusters (miR-17 ~ 92, miR-106a ~ 363,
and miR-106b ~ 25) are some of the best-characterized polycistronic miRNAs. They encode 15 individual miRNAs and
are grouped into 4 “seed” families (miR-17, miR-18, miR19, and miR-92) [104]. Many oncogenic transcription factors have been reported that regulate the expression of miR17 ~ 92 cluster, including MYC, MYCN, and E2F family,
e.g. E2F1, E2F2, and E2F3, which are critical for cell cycle
procession [105–107], therefore, cycling cells are likely to
have elevated levels of miR-17 ~ 92. That could explain that
miR-17 ~ 92 was highly increased in stage 2 of iNKT cells,
where iNKT cells undergo quick expansion. Mice lacking
all 3 miR-17 ~ 92 family clusters (triple knockout, TrKO)
had markedly reduced iNKT cell frequency and absolute
number. iNKT cells that can be isolated from TrKO mice
display a severely immature phenotype, and the mice have
an increased level of iNKT2 cells and reduced iNKT1 and
iNKT17 cells, which is similar to what is seen in Dicer KO
mice. iNKT cell maturation defect we observed in TrKO
phenocopy the maturation defect we observed in overall
miRNAs deletion mice (Dicer KO). Of note, iNKT cells
with a deletion in the miR-17 ~ 92 family show increased
TGF-βRII expression but relatively normal TGF-βRI expression. Furthermore, in developing iNKT cells, TGF-βRII and
its downstream molecules pSMAD2/3 show an expression
pattern that is inverse to miR-17 ~ 92 family clusters. Consistently, TGF-βRII expression and signaling are augmented
in Dicer KO iNKT cells [32]. Therefore, Fedeli et al. suggest that miR-17 ~ 92 family clusters may directly target and
fine-tune TGF-β signaling at stage 2, controlling iNKT cell
terminal maturation. Finally, genetic ablation of TGF-β signaling in the absence of miRNAs rescues iNKT cell maturation and differentiation [32]. Overall, miR-17 ~ 92 could be
the prominent miRNA that direct the final steps of iNKT cell
maturation by targeting on TCF-βII.
Overall, these studies clearly demonstrate that miRNAs
direct important functions during the regulation of iNKT
cell development, maturation, and homeostasis. Positive
and negative regulation by individual miRNAs was often
achieved through the modulation of key signaling pathways.
Multiple miRNAs may coordinately regulate shared signaling pathways to induce integrated broad changes in related
signaling networks, such as the TCR signaling pathway,
while individual miRNAs might target multiple molecules
to induce cumulative effects during multiple stages of iNKT
cell development and activation.
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Conclusions
Tremendous progress has been made in identifying the
transcription factors and signal transduction components
involved in iNKT cell development and function. However,
the mechanisms controlling the expression of these factors
and coordinating their activities in promoting iNKT cell
positive selection, lineage specification, acquisition of functional activity, and homeostasis remain mysterious. As the
functions of miRNAs in regulating iNKT cell development
and function become evident, the potential roles of miRNAs
as key intermediates in the molecular networks of iNKT cell
regulation become clear. The ability of individual miRNAs
to target molecules in crucial signaling pathways related to
iNKT cell differentiation and maturation emphasizes the
critical role of miRNAs in iNKT cell modulation. Until
now, individual miRNAs, including miR-150, miR-155,
miR-181, let-7, miR-17 ~ 92 cluster, and miR-183C have
been reported that exhibit dynamic expression pattern during
iNKT cells development, and play critical roles by targeting
key signature markers for iNKT cell development and function (Fig. 1). Beyond those, miR-133b was also considered
as a regulator for iNKT17 cell differentiation by targeting
Th-POK in NOD mice [108]. However, miRNAs dynamic
regulation does not always support iNKT cell functional relevance, for example, despite prominent and highly dynamic
expression in thymocytes and iNKT cells, miR-21 [109] and
miR-223 [34] expression may not be required for iNKT cell
development and function. Since multiple miRNAs regulate
cellular events and may act redundantly [110], it is possible
that the unaffected iNKT cell development in miR-21 KO
and miR-233 KO could be due to redundant function on
cellular events regulated by multiple miRNAs. It has been
well known that TCR signaling plays a critical role in subset differentiation [111–113], weakened TCR signaling led
to abrogation in iNKT2 and to a lesser extent iNKT17 cell
development, while not reducing iNKT1 cell development
[111, 114]. Among the miRNAs reviewed above, both miR155 and miR-17 ~ 92 cluster family have been reported could
be induced upon TCR activation [115]. And miR-181, miR183C, and miR-155 have been considered are implicated in
TCR signaling strength in some degrees [33, 35, 39, 63].
Since Mucosal-Associated Invariant T (MAIT) cells share
at least some developmental features with iNKT cells, both
iNKT cell and MAIT cell are selected on DP thymocytes
and depend on PLZF. However, thymic MAIT cells can be
divided into MAIT1 and MAIT17 cells in the mature stage
[116]. In fact, investigations of MAIT cells unveiled that
miRNAs are MAIT cells required for MAIT cells development as well [117]. The role of individual miRNAs, such as
miR-181 and miR-155, in MAIT cell development have been
reported. Similar to iNKT cells, miR-181 could regulate
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MAIT cells via regulating TCR signal, deletion of miR-181
mice displayed an almost complete block in early MAIT
cells development, resulting in dramatically reduced MAIT
cell number [118]. Strikingly, like iNKT cells, overexpression of miR-155 reduces MAIT cell frequency and number, and blocks MAIT17 differentiation. Both iNKT17 and
MAIT17 cells decreased in miR-155 overexpression mice
indicated that miR-155 targets on signature transcription
factors, such as Rictor, in innate T cells development [119].
However, MAIT1 cells in miR-155 overexpression MAIT
cells are increased, the discrepancy of miRNAs in regulating
iNKT cells and MAIT cells could due to the differentiation
programs between iNKT cells and MAIT cells are different.
Future investigations that identify new miRNAs, elucidate
miRNA targets, and reveal the molecular mechanisms of
miRNA regulation will not only provide new perspectives
on the key molecular mechanisms of iNKT cell regulation
but will also offer opportunities to identify novel genes and
pathways involved in the iNKT cell regulatory network.
Important challenges remain to identify the related molecular mechanisms among various miRNAs and to understand
how they control the integrated context of iNKT cell differentiation, homeostasis, and function. These studies will
ultimately form the basis for future utilization of iNKT cells
in disease diagnosis and therapies.
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